DNA Ploidy and Proliferative Activity in Childhood Soft-Tissue Sarcomas
Author Information
Author(s): F.K. Nigglil, J.E. Powell, S.E. Parkes, K. Ward, F. Raafat, J.R. Mann, M.C.G. Stevens
Primary Institution: The Children's Hospital, Birmingham, UK
Hypothesis
The study investigates the prognostic value of DNA ploidy and S-phase in childhood soft-tissue sarcomas.
Conclusion
DNA content and S-phase significantly impact prognosis in childhood soft-tissue sarcomas, with hyperdiploid rhabdomyosarcomas associated with better outcomes.
Supporting Evidence
- Five-year survival was 63.4% for all soft-tissue sarcomas and 69.4% for rhabdomyosarcomas.
- 65.5% of rhabdomyosarcomas were aneuploid compared to 23% of extraosseous Ewing's and 31% of non-rhabdomyosarcomas.
- Median S-phase was significantly higher in rhabdomyosarcomas (17.0%) than in other soft-tissue sarcomas (10.8%).
- Hyperdiploid rhabdomyosarcomas had a five-year survival rate of 88.3% compared to 28.6% for tetraploid tumors.
Takeaway
This study looks at how the DNA of tumors in children can help doctors understand which kids might need more or less treatment.
Methodology
A retrospective study analyzing clinical, histological, and flow cytometric parameters in 128 cases of soft-tissue sarcoma.
Limitations
The study's findings may not be generalizable due to the small number of non-rhabdomyosarcomatous soft-tissue sarcomas analyzed.
Participant Demographics
Patients were children under 16 years old treated at The Children's Hospital Birmingham between 1980 and 1992.
Statistical Information
P-Value
0.0003
Confidence Interval
2.85-32.57
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website